首页> 外文OA文献 >Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

【2h】

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

机译：Nepa的疗效，Netupitant和Palonosetron的固定止吐组合，与在随机相3研究中接受高均匀化疗（HEC）的中国患者中预防化疗诱导的恶性和呕吐（CINV）的3天的抑制剂方案

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jianhua Chang; Gongyan Chen; Dong Wang; Guihua Wang; Shun Lu; Jifeng Feng; Wei Li; Ping Li; Corinna Lanzarotti; Salvatore Chessari; Li Zhang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study [J] . Jianhua Chang, Gongyan Chen, Dong Wang, Cancer Medicine . 2020,第14期

机译：Nepa的疗效，Netupitant和Palonosetron的固定止吐组合，与在随机相3研究中接受高均匀化疗（HEC）的中国患者中预防化疗诱导的恶性和呕吐（CINV）的3天的抑制剂方案
2. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [J] . LZhang, SLu, JFeng, Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第2期

机译：评估单剂量NEPA，Netupitant和Palonosetron的固定止吐组合的功效的随机期III研究与预防高均匀化疗（HEC）的患者预防化疗诱导的化疗诱导的恶心和呕吐（CINV）的试剂
3. Efficacy of triplet regimen antiemetic therapy for chemotherapy‐induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single‐shot palonosetron and consecutive‐day granisetron for CINV in a randomized, single‐blinded crossover study [J] . Akihiko Takeuchi, Hideji Nishida, Hiroaki Kimura, Cancer Medicine . 2015,第3期

机译：三联疗法止吐疗法对接受高度呕吐治疗的骨和软组织肉瘤患者化疗引起的恶心和呕吐（CINV）的疗效，以及单次帕洛诺司琼和连续一日Granisetron在随机，单次使用盲交叉研究
4. Aprepitant for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting in Children: Overcoming Barriers [D] . Patel, Priya 2018

机译：预防急性化疗引起的儿童恶心和呕吐的阿瑞品：克服障碍
5. Efficacy of NEPA a fixed antiemetic combination of netupitant and palonosetron vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study [O] . Jianhua Chang, Gongyan Chen, Dong Wang, 2020

机译：一项随机3期研究显示NEPAnetupitant和palonosetron的固定止吐药与3天抗精神病药在预防因化学疗法引起的恶心和呕吐（CINV）的患者中的预防作用为3天
6. Phase 3 efficacy results of a single dose of NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients [O] . L. Zhang, S. Lu, A. Dechaphunkul, 2017

机译：单剂量NEPA的疗效结果，Netupitant和Palonosetron的固定组合，与用于预防中国患者的化疗诱导的化疗诱导的恶心和呕吐（CINV）的3天的3天

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

著录项

引文网络

相似文献

相关主题

期刊订阅